Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic regulation of prostate cancer heterogeneity and plasticity
Claudia Peitzsch, Ielizaveta Gorodetska, Daria Klusa, et al.
Seminars in Cancer Biology (2020) Vol. 82, pp. 94-119
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
Anna Mukha, Uğur Kahya, Annett Linge, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 7844-7868
Open Access | Times Cited: 110
Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 22
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Francesco Lasorsa, Nicola Antonio di Meo, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 910-910
Open Access | Times Cited: 31
Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer
Junyu Li, Lin Li, Peimeng You, et al.
Seminars in Cancer Biology (2023) Vol. 91, pp. 35-49
Closed Access | Times Cited: 29
ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 15
Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
Guoqiang Liu, Minggang Zhu, Mingrui Zhang, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1287-1287
Open Access | Times Cited: 21
Enhancing Metabolome Annotation by Electron Impact Excitation of Ions from Organics-Molecular Networking
Xinxin Wang, Xiaoshan Sun, Fubo Wang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 4, pp. 1444-1453
Closed Access | Times Cited: 6
Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
Laure Cayrefourcq, Frédéric Thomas, Thibault Mazard, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 36
Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
T. Pejcic, Zoran Todorović, Siniša Đurašević, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2939-2939
Open Access | Times Cited: 14
Metformin-induced oxidative stress inhibits LNCaP prostate cancer cell survival
Sashana Dixon, Alice Tran, Matthew Schrier, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells
Paul T. Morse, Junmei Wan, Tasnim Arroum, et al.
Biomolecules (2024) Vol. 14, Iss. 6, pp. 695-695
Open Access | Times Cited: 4
Estrogen-related receptor alpha (ERRα) controls the stemness and cellular energetics of prostate cancer cells via its direct regulation of citrate metabolism and zinc transportation
Taiyang Ma, Wenjuan Xie, Zhenyu Xu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Amino Acid Transporters on the Guard of Cell Genome and Epigenome
Uğur Kahya, Ayşe Sedef Köseer, Anna Dubrovska
Cancers (2021) Vol. 13, Iss. 1, pp. 125-125
Open Access | Times Cited: 25
Lysine 53 Acetylation of Cytochrome c in Prostate Cancer: Warburg Metabolism and Evasion of Apoptosis
Viktoriia Bazylianska, Hasini A. Kalpage, Junmei Wan, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 802-802
Open Access | Times Cited: 25
Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment
Manish Kumar Singh, Sunhee Han, Sung Soo Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11185-11185
Open Access | Times Cited: 3
Plasticity within Aldehyde Dehydrogenase–Positive Cells Determines Prostate Cancer Radiosensitivity
Franziska M. Schwarz, Iñaki Schniewind, María José Besso, et al.
Molecular Cancer Research (2022) Vol. 20, Iss. 5, pp. 794-809
Open Access | Times Cited: 14
Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance
Anmbreen Jamroze, Xiaozhuo Liu, Dean G. Tang
(2024), pp. 1-35
Open Access | Times Cited: 2
Identification of Prognostic Metabolomic Biomarkers at the Interface of Mortality and Morbidity in Pre-Existing TB Cases Infected With SARS-CoV-2
Ilhame Diboun, Farhan Cyprian, Najeha Anwardeen, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 9
FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells
Wenping Lian, Zhongquan Wang, Yajie Ma, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-33
Open Access | Times Cited: 9
Druggable Metabolic Vulnerabilities Are Exposed and Masked during Progression to Castration Resistant Prostate Cancer
Stephen Yiu Chuen Choi, Caroline F. Ribeiro, Yuzhuo Wang, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1590-1590
Open Access | Times Cited: 9
Untargeted metabolomics reveals alterations in the metabolic reprogramming of prostate cancer cells by double-stranded DNA-modified gold nanoparticles
Yuting Zhang, Jundong Lin, Yangjia Zhuo, et al.
Biomaterials Advances (2022) Vol. 135, pp. 212745-212745
Open Access | Times Cited: 8
HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1
Hang You, Guojing Song, Zhizhen Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy
Hao Liang, Bin Zhou, Pei-Xin Li, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Functional metabolome profiling may improve individual outcomes in colorectal cancer management implementing concepts of predictive, preventive, and personalized medical approach
Yuan Yu, Chenxin Yang, Wang Ying-zhi, et al.
The EPMA Journal (2022) Vol. 13, Iss. 1, pp. 39-55
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top